Amgen ( AMGN) was under pressure Tuesday after telling analysts it expects to earn $2.71 to $2.85 a share on revenue of $11 billion to $11.5 billion in 2005.

Analysts surveyed by Thomson One Analytics were forecasting earnings of $2.83 a share on revenue of $11.75 billion for the full year. The stock was recently down $1.71, or 2.8%, to $58.40.

The company didn't offer specific guidance for 2004, during which analysts expect it to earn $2.38 a share on revenue of $10.13 billion.

Longer term, Amgen expects product revenue to rise at a compound annual rate of 30% to 32% through 2005, with adjusted earnings rising 25% to 27% over the same period. The growth rates assume no acquisitions or product in-licensing and that the company's "present understanding of Medicare reimbursement changes remains limited."

If you liked this article you might like

Spain to Play Netherlands for World Cup

Spain to Play Netherlands for World Cup

Wal-Mart: Analysts' Upgrades, Downgrades

Wal-Mart: Analysts' Upgrades, Downgrades

Netherlands Advances to World Cup Final

Netherlands Advances to World Cup Final

Apple: Analysts' Upgrades, Downgrades

Apple: Analysts' Upgrades, Downgrades

World Markets Mostly Lower Monday

World Markets Mostly Lower Monday